3,3',5-triiodothyroacetic acid has been researched along with Pituitary Neoplasms in 2 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the response of TSH secretion to 3,5,3'-triiodothyronine (T3) and 3,5,3'-triiodothyroacetic acid (Triac) in patients with resistance to thyroid hormone, and compared the responses with those in patients with TSH-secreting pituitary adenoma and normal subjects." | 3.69 | Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone. ( Fukata, S; Kuma, K; Ohsawa, N; Sakata, S; Shimizu, N; Takamatsu, J; Tanaka, K; Ueda, S; Yamaji, T, 1996) |
| "After successful treatment of hyperthyroidism, SHBG levels normalized in patients with nIST, but they did not change in patients with nnIST." | 1.28 | Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. ( Beck-Peccoz, P; Brabant, G; Faglia, G; Forloni, F; Marcocci, C; Mariotti, S; Medri, G; Pinchera, A; Roncoroni, R, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueda, S | 1 |
| Takamatsu, J | 1 |
| Fukata, S | 1 |
| Tanaka, K | 1 |
| Shimizu, N | 1 |
| Sakata, S | 1 |
| Yamaji, T | 1 |
| Kuma, K | 1 |
| Ohsawa, N | 1 |
| Beck-Peccoz, P | 1 |
| Roncoroni, R | 1 |
| Mariotti, S | 1 |
| Medri, G | 1 |
| Marcocci, C | 1 |
| Brabant, G | 1 |
| Forloni, F | 1 |
| Pinchera, A | 1 |
| Faglia, G | 1 |
2 other studies available for 3,3',5-triiodothyroacetic acid and Pituitary Neoplasms
| Article | Year |
|---|---|
Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
Topics: Adenoma; Adolescent; Child, Preschool; Female; Ferritins; Glycoprotein Hormones, alpha Subunit; Huma | 1996 |
Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.
Topics: Adenoma; Adolescent; Adult; Child; Diagnosis, Differential; Drug Resistance; Female; Humans; Hyperth | 1990 |